Clinical implications of C-reactive protein as a predictor of vascular risk

Journal of the American Academy of Nurse Practitioners

Volumn 19, Issue 7, 2007, Pages 335-340

  Katrinchak, Carolyn ^a   Fritz, Kathryn ^a  

^a NONE

Author keywords

CRP; Heart disease; hs CRP; Inflammation

Indexed keywords

EID: 34547674615     PISSN: 10412972     EISSN: 17457599     Source Type: Journal    
DOI: 10.1111/j.1745-7599.2007.00234.x     Document Type: Article

References (20)

1. American Heart Association 2005a). Heart Disease and Stroke Statistics: 2005 Update. Abstract retrieved September 5, 2005 http://www.americanheart.org/ downloadable/heart/1105390918119HDSStats2005Update.pdf
2. American Heart Association (2005b). Risk factors and coronary heart disease. Abstract retrieved October 6, 2005, from http://www.americanheart.org/ presenter.jhtml?identifier=500
3. Clyne, B. Olshaker, J. S 1999). The C-reactive protein. Journal of Emergency Medicine, 17 (6 1019 1025.
4. Cotran, R., Kumar, V. Collins, T 1999). Bobbins pathologic basis of disease (6th ed Philadelphia, PA : W.B. Saunders Company.
5. Hansson, G 2005). Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine, 352, 1685 1695.
6. Libby, P. Ridker, P 2004). Inflammation and atherosclerosis: Role of C-reactive protein in risk assessment. American Journal of Medicine, 116, 9S.
7. MacKenzie, J 2004). Predicting CAD events: C-reactive protein, a marker for atherosclerotic risk. Nurse Practitioner, 29 (6 14 27.
8. Nissen, S., Murat Tuzcu, E., Schoenhagen, P., Sasiela, W. J., Tsai, J., Orazem, J., et al 2005). Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. New England Journal of Medicine, 352, 29 38.
9. Paoletti, R., Gotto, A. M. Jr. Hajjar, D. P 2004). Inflammation in atherosclerosis and implications for therapy. Circulation, 109 (Suppl. III III-20 III-26.
10. Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., et al 2003). Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, 499 511.
11. Ridker, P. M 2003a). Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation, 107, 363 369.
12. Ridker, P. M 2003b). High sensitivity C-reactive protein and cardiovascular risk: Rationale for screening and primary prevention. American Journal of Cardiology, 92 (Suppl 17K 22K.
13. Ridker, P. M., Buring, J. E., Cook, N. R. Rifai, N 2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14,719 initially healthy American women. Circulation, 107, 391 397.
14. Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., et al 2005). C-reactive protein levels and outcomes after statin therapy. New England Journal of Medicine, 352, 20 28.
15. Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P. Hennekens, C. H 1997). Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine, 336, 973 979.
16. Ridker, P. M., Nader, R., Lynda, R., Buring, J. E. Cook, N. R 2002). Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine, 347 (20 1557 1565.
17. Rifai, N 2001). C-reactive protein and coronary heart disease: Diagnostic and therapeutic implications for primary prevention. Cardiovascular Toxicology, 1 (2 153 157.
18. Rost, N. S., Wolf, P. A., Kase, C. S., Kelly-Hayes, M., Silbershatz, H., Massaro, J. M., et al 2001). Plasma concentration of c-reactive protein and risk of ischemic stroke and transient ischemic attack. Stroke, 32, 2575 2579.
19. Willerson, J. Ridker, P 2004). Inflammation as a cardiovascular risk factor. Circulation, 109 (Suppl. II II-2 II-10.
20. Wilson, A. M., Ryan, M. C. Boyle, A. J 2006). The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen. International Journal of Cardiology, 106, 291 297.